270 related articles for article (PubMed ID: 23818062)
21. Cytokine induced apoptosis in human retinoblastoma cells.
Cullinan AE; Brandt CR
Mol Vis; 2004 Apr; 10():315-22. PubMed ID: 15133451
[TBL] [Abstract][Full Text] [Related]
22. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
23. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
[TBL] [Abstract][Full Text] [Related]
24. Panax notoginseng saponins induce apoptosis in retinoblastoma Y79 cells via the PI3K/AKT signalling pathway.
Liu J; Zhang C; Jia B; Dong K; Li M; Qiu D; Li L; Xu B; Sun S; Li C
Exp Eye Res; 2022 Mar; 216():108954. PubMed ID: 35074343
[TBL] [Abstract][Full Text] [Related]
25. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
[TBL] [Abstract][Full Text] [Related]
26. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture.
Albert DM; Nickells RW; Gamm DM; Zimbric ML; Schlamp CL; Lindstrom MJ; Audo I
Ophthalmic Genet; 2002 Sep; 23(3):137-56. PubMed ID: 12324873
[TBL] [Abstract][Full Text] [Related]
28. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins.
Wagner N; Wagner KD; Sefton M; Rodríguez-Tébar A; Grantyn R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1932-9. PubMed ID: 10845619
[TBL] [Abstract][Full Text] [Related]
29. Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138.
Muñoz M; Rosso M; Coveñas R; Montero I; González-Moles MA; Robles MJ
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2775-81. PubMed ID: 17525212
[TBL] [Abstract][Full Text] [Related]
30. RB116: an RB1+ retinoblastoma cell line expressing primitive markers.
Bejjani A; Choi MR; Cassidy L; Collins DW; O'Brien JM; Murray T; Ksander BR; Seigel GM
Mol Vis; 2012; 18():2805-13. PubMed ID: 23233783
[TBL] [Abstract][Full Text] [Related]
31. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line.
Murray TG; Cicciarelli N; McCabe CM; Ksander B; Feuer W; Schiffman J; Mieler WF; O'Brien JM
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2516-22. PubMed ID: 9375570
[TBL] [Abstract][Full Text] [Related]
32. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
[TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
Chung KS; Cho SH; Shin JS; Kim DH; Choi JH; Choi SY; Rhee YK; Hong HD; Lee KT
Carcinogenesis; 2013 Feb; 34(2):331-40. PubMed ID: 23125221
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
35. Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells.
Mergler S; Cheng Y; Skosyrski S; Garreis F; Pietrzak P; Kociok N; Dwarakanath A; Reinach PS; Kakkassery V
Exp Eye Res; 2012 Jan; 94(1):157-73. PubMed ID: 22182671
[TBL] [Abstract][Full Text] [Related]
36. Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals.
Wang F; Liu Y; Bi Z
J Recept Signal Transduct Res; 2017 Feb; 37(1):94-99. PubMed ID: 27133446
[TBL] [Abstract][Full Text] [Related]
37. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma.
Wu N; Chen S; Luo Q; Jiang Z; Wang X; Li Y; Qiu J; Yu K; Yang Y; Zhuang J
Exp Eye Res; 2022 Mar; 216():108955. PubMed ID: 35074341
[TBL] [Abstract][Full Text] [Related]
38. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
[TBL] [Abstract][Full Text] [Related]
39. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma.
Dimaras H; Coburn B; Pajovic S; Gallie BL
Mol Carcinog; 2006 May; 45(5):333-43. PubMed ID: 16555252
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
